Primary Ovarian Insufficiency: Clinical Trials

180 trials for Primary Ovarian Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

56 completed, 55 unknown, 22 recruiting, 17 not yet recruiting. 49 Not applicable, 36 Phase 2, 35 Phase 1, 10 Phase 3, 10 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable49Unknown 14, Completed 12, Not yet recruiting 7, Recruiting 6, Active not recruiting 4, Terminated 3, Withdrawn 2, Suspended 1
Phase 236Unknown 12, Completed 11, Not yet recruiting 3, Recruiting 3, Active not recruiting 2, Terminated 2, Withdrawn 2, Suspended 1
Phase 135Unknown 13, Completed 11, Active not recruiting 3, Not yet recruiting 3, Recruiting 2, Suspended 1, Terminated 1, Withdrawn 1
Phase 310Terminated 4, Completed 3, Recruiting 2, Withdrawn 1
Phase 410Completed 5, Unknown 3, Recruiting 1, Withdrawn 1
Early Phase 15Active not recruiting 1, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Primary Ovarian Insufficiency: new trials by email Literature Review of Primary Ovarian Insufficiency trials Research Report on Primary Ovarian Insufficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral GDC-0077 in Premature Ovarian Insufficiency
GDC-0077 - Primary Ovarian Insufficiency
Phase 1Not yet recruitingWomen's Hospital School Of Medicine Zhejiang University122026-10-302026-10-29
Effect and Mechanism of Jiajian Guishen Optimized Formula on Premature Ovarian Insufficiency: Insights Into m6A Modification and Oxidative Stress
JJGS - Premature Ovarian Insufficiency
Early Phase 1Not yet recruitingShi Yun452026-09-302026-09-25
Finerenone for Premature Ovarian Insufficiency (POI)
Finerenone, Placebo - Premature Ovarian Insufficiency
Phase 2Not yet recruitingThe University of Hong Kong-Shenzhen Hospital462026-09-152026-09-11
Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome
Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch - Turner Syndrome, Primary Ovarian Insufficiency
Phase 2Not yet recruitingChildren's National Research Institute152026-09-012026-08-25
Ovarian Tissue Allo-transplantation
Ovarian tissue allo-transplantation - Ovarian Failure, Ovarian Insufficiency
Not applicableNot yet recruitingUniversity Hospitals Cleveland Medical Center102026-09-012026-07-23
Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI
hUC-MSCs Injection (Phase I), hUC-MSCs Injection (Phase IIa), Placebo - Premature Ovarian Insufficiency
Phase 1 / Phase 2RecruitingShenzhen Wingor Biotechnology Co., Ltd.592026-08-032026-08-20
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
Primary Ovarian Insufficiency, Premature Menopause
RecruitingMassachusetts General Hospital452026-06-222026-09-08
Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
Fermented Poi - Gestational Diabetes Mellitus (GDM), Pregnancy
Not applicableRecruitingUniversity of Hawaii502026-06-122026-07-02
Genetic Variants in Idiopathic Premature Ovarian Insufficiency
Premature Ovarian Insufficiency
Not yet recruitingAbdurrahman Hamdi İnan1002026-06-102026-05-19
Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)
Perimenopause, Perimenopause-Related Depression
Enrolling by invitationHealing Hope International122026-06-012026-04-06
A Retrospective and Prospective Clinical Registry for Data Collection of Perimenopausal, Menopausal and Premature Ovarian Insufficiency Women
Menopause, Menopausal Hormone Therapy
Not yet recruitingIRCCS San Raffaele50002026-06-012026-05-26
Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Primary Ovarian Insufficiency
HS_SW01 cells injection - Primary Ovarian Insufficiency (Poi)
Phase 1 / Phase 2Not yet recruitingShenzhen Huishan Biotechnology Co., Ltd.212026-04-152026-04-27
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Triple Negative Breast Cancer (TNBC)
Not yet recruitingPeter MacCallum Cancer Centre, Australia752026-04-082026-04-14
A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insufficiency
YT023, Control Arm (Conventional Therapy) - Premature Ovarian Insufficiency
Phase 1 / Phase 2Active not recruitingInternational Peace Maternity and Child Health Hospital602026-03-202026-04-03
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
Primary Ovarian Insufficiency, Azoospermia
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)5002026-03-112026-03-16
Improving Outcomes in Early Menopause After Cancer
Nurse Navigator Intervention, Education Control - Early Menopause, Cancer
Not applicableRecruitingDuke University1172026-01-202026-05-14
A RCT Study on Autologous PRP Injection in Patients With POR
PRP injection - Poor Ovarian Response, PRP Injection
Not applicableNot yet recruitingPeking University Third Hospital1422025-12-152025-12-15
A RCT Study on Autologous Cell Injection Into the Ovaries of Patients With POR
PRP injection, SVF injection - Poor Ovarian Response
Not applicableNot yet recruitingPeking University Third Hospital1982025-12-152025-12-15
Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults
Questionnaire - Acute Leukemia
Not applicableCompletedUniversity Hospital, Bordeaux512025-09-192026-06-25
Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency
Huanjingjian decoction, Hormone replacement therapy, Placebo - Premature Ovarian Insufficiency
Not applicableNot yet recruitingShanghai Pulmonary Hospital, Shanghai, China2762025-09-012025-09-08

Showing 20 of 180. Sign in to see all of them.

Narrower conditions

Infertility (22)  ·  Menopause, Premature (17)  ·  Infertility, Female (10)  ·  Turner Syndrome (10)  ·  Polycystic Ovary Syndrome (6)  ·  Hypogonadism (5)  ·  Amenorrhea (4)  ·  Breast Neoplasms (3)  ·  Cardiovascular Diseases (3)  ·  Cognitive Dysfunction (3)  ·  Endometriosis (3)  ·  Osteoporosis (3)  ·  Autoimmune Diseases (2)  ·  Azoospermia (2)

Broader conditions

Adnexal Diseases (180)  ·  Female Urogenital Diseases (180)  ·  Female Urogenital Diseases and Pregnancy Complications (180)  ·  Genital Diseases (180)  ·  Genital Diseases, Female (180)  ·  Urogenital Diseases (180)  ·  Endocrine System Diseases (179)  ·  Gonadal Disorders (179)  ·  Ovarian Diseases (179)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14)  ·  Genetic Diseases, Inborn (14)  ·  Male Urogenital Diseases (14)  ·  Heart Diseases (13)  ·  Cardiovascular Diseases (12)

Interventions

Estradiol (7)  ·  Dehydroepiandrosterone (5)  ·  Progesterone (5)  ·  Surveys and Questionnaires (5)  ·  Injections (4)  ·  Saline Solution (4)  ·  Chorionic Gonadotropin (3)  ·  Hormone Replacement Therapy (3)  ·  Lisdexamfetamine Dimesylate (3)  ·  Stem Cell Transplantation (3)  ·  Blood Specimen Collection (2)  ·  Ethinyl Estradiol (2)  ·  Filgrastim (2)  ·  Follicle Stimulating Hormone (2)  ·  Goserelin (2)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (11)  ·  University of Pennsylvania (7)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  Cengiz Gokcek Women's and Children's Hospital (4)  ·  Center for Human Reproduction (4)  ·  Peking University Third Hospital (4)  ·  Shi Yun (4)  ·  Chinese Academy of Sciences (3)  ·  International Peace Maternity and Child Health Hospital (3)  ·  Radboud University Medical Center (3)  ·  University Hospital, Bordeaux (3)  ·  ART Fertility Clinics LLC (2)  ·  Affiliated Hospital of Nantong University (2)  ·  Al-Azhar University (2)  ·  Ankara City Hospital Bilkent (2)

Countries

United States (45)  ·  China (40)  ·  Egypt (10)  ·  France (10)  ·  Turkey (Türkiye) (10)  ·  Netherlands (8)  ·  Greece (4)  ·  Italy (4)  ·  Spain (4)  ·  Canada (3)  ·  Germany (3)  ·  United Arab Emirates (3)  ·  Denmark (2)  ·  Iran (2)  ·  Japan (2)

Top investigators

Norbert Gleicher, MD (4)  ·  C. Neill Epperson, MD (3)  ·  Clarisa R Gracia, MD, MSCE (2)  ·  David Barad, MD, MS (2)  ·  Dongmei Lai, M.D. (2)  ·  Hala Gabr, MD (2)  ·  Hala N Hosni, Professor (2)  ·  Hongmei Wang, Doctor (2)  ·  Ke Xu, Master (2)  ·  Laura Melado, PhD (2)  ·  Lawrence M Nelson, M.D. (2)  ·  Mahmoud Edessy, Professor (2)  ·  Medhat Kamel, Msc (2)  ·  Mohammad AM Ahmed, MD (2)  ·  Naoto Ueno, MD, PhD (2)

Results publications

PMID 27008889, PMID 29486615, PMID 20424285, PMID 30796792, PMID 32195207, PMID 18480812, PMID 20351977, PMID 21479340, PMID 27022685, PMID 30134239, PMID 30541396, PMID 31376814, PMID 33407794, PMID 101855, PMID 10582785, PMID 11498213, PMID 11821109, PMID 12396892, PMID 15919682, PMID 16213850, PMID 18326616, PMID 18403419, PMID 18551082, PMID 19066296, PMID 19520713, PMID 20395876, PMID 21134950, PMID 21316664, PMID 21880799, PMID 21917867, PMID 21994953, PMID 22271773, PMID 22282904, PMID 22284905, PMID 22343553, PMID 22512465, PMID 22698640, PMID 23182561, PMID 23212100, PMID 23678038, PMID 23902317, PMID 24341612, PMID 24406076, PMID 24473536, PMID 24905063, PMID 24945456, PMID 24982681, PMID 25585505, PMID 25686030, PMID 25881987

NIH funding

R21CA301298 (1)